Science

Erick Saldanha: Proud to wrap up February with 2 publications

Erick Saldanha/X

Mar 4, 2025, 05:32

Erick Saldanha: Proud to wrap up February with 2 publications

Erick Saldanha, Medical Oncologist and Postdoctoral Clinical Fellow at Princess Margaret Cancer Centre, shared a post on LinkedIn:

“Proud to wrap up February with 2 publications!

1) We report the largest HER2-mutant NSCLC cohort in Latin America.

Thanks to the amazing support of Vladmir Cordeiro de Lima, Marcelo Corassa, Andrés Felipe Cardona Zorrilla, Leonardo Gil Santana and all the authors!

Real-world characteristics and outcomes of ***ERBB2-*mutant NSCLC in Latin American patients (CLICaP).**

Authors: Erick F Saldanha, et al.

Erick Saldanha: Proud to wrap up February with 2 publications

2) We highlight the role of ctDNA kinetics in predicting treatment outcomes for patients with NSCLC.”

Plasma ctDNA kinetics as a predictor of systemic therapy response for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors: Luís F Leite da Silva, et al.

Erick Saldanha: Proud to wrap up February with 2 publications

Andrés Felipe Cardona Zorrilla cancer ctDNA ERBB2 Erick Saldanha February fight against cancer Global fight against cancer HER2 Leonardo Gil-Santana Luís F Leite da Silva Marcelo Corassa MedOnc non small cell lung cancer NSCLC OncoDaily Oncology Princess Margaret Cancer Centre Vladmir Cordeiro de Lima

Beyond the Red Carpet: Oscar Winners and Nominees Who Fought Cancer

Oncologist Near Me – Lidia Schapira: A Leader in Cancer Care and Medical Education

CancerWorld welcomes their Co-Editors-in-Chief

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma